Validation of the Seattle Heart Failure Model in a Community-Based Heart Failure Population and Enhancement by Adding B-Type Natriuretic Peptide

Management of heart failure (HF) remains complex with low 5-year survival. The Seattle Heart Failure Model (SHFM) is a recently described risk score derived predominantly from clinical trial populations that may enable the prediction of survival in patients with HF. This study sought to validate the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2007-08, Vol.100 (4), p.697-700
Hauptverfasser:	May, Heidi T., MSPH, Horne, Benjamin D., PhD, MPH, Levy, Wayne C., MD, Kfoury, Abdallah G., MD, Rasmusson, Kismet D., FNP, Linker, David T., MD, Mozaffarian, Dariush, MD, DrPH, Anderson, Jeffrey L., MD, Renlund, Dale G., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences Biomarkers - blood Cardiology. Vascular system Cardiovascular Clinical trials Confidence Intervals Female Follow-Up Studies Heart Heart failure Heart Failure - blood Heart Failure - epidemiology Heart Failure - therapy Heart failure, cardiogenic pulmonary edema, cardiac enlargement Heart Transplantation Heart-Assist Devices Humans Male Medical sciences Middle Aged Natriuretic Peptide, Brain - blood Peptides Population Surveillance Prognosis Prospective Studies Studies Survival analysis Survival Rate - trends Time Factors Validity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!